normetanephrine has been researched along with Diabetes Mellitus, Type 2 in 3 studies
Normetanephrine: A methylated metabolite of norepinephrine that is excreted in the urine and found in certain tissues. It is a marker for tumors.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bromocriptine-QR is a sympatholytic dopamine D2 agonist for the treatment of type 2 diabetes that has demonstrated rapid (within 1 year) substantial reductions in adverse cardiovascular events in this population by as yet incompletely delineated mechanisms." | 1.72 | Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects. ( Adams, J; Agyin, C; Alatrach, M; Cersosimo, E; Chamarthi, B; Chilton, R; Cincotta, AH; Cominos, N; DeFronzo, RA; Ezrokhi, M; Triplitt, C, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cincotta, AH | 1 |
| Cersosimo, E | 1 |
| Alatrach, M | 1 |
| Ezrokhi, M | 1 |
| Agyin, C | 1 |
| Adams, J | 1 |
| Chilton, R | 1 |
| Triplitt, C | 1 |
| Chamarthi, B | 1 |
| Cominos, N | 1 |
| DeFronzo, RA | 1 |
| Robeva, R | 1 |
| Nedyalkova, M | 1 |
| Kirilov, G | 1 |
| Elenkova, A | 1 |
| Zacharieva, S | 1 |
| Kudłak, B | 1 |
| Jatkowska, N | 1 |
| Simeonov, V | 1 |
| Singer, J | 1 |
| Koch, CA | 1 |
| Kassahun, W | 1 |
| Lamesch, P | 1 |
| Eisenhofer, G | 1 |
| Kluge, R | 1 |
| Lincke, T | 1 |
| Seiwerts, M | 1 |
| Borte, G | 1 |
| Schierle, K | 1 |
| Paschke, R | 1 |
3 other studies available for normetanephrine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects.
Topics: Bromocriptine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glycogen Synthase Kinase 3 beta; | 2022 |
Multivariate Statistical Approach for Nephrines in Women with Obesity.
Topics: Adolescent; Adult; Aged; Biomarkers; Cluster Analysis; Diabetes Mellitus, Type 2; Female; Humans; Me | 2021 |
A patient with a large recurrent pheochromocytoma demonstrating the pitfalls of diagnosis.
Topics: Abdominal Pain; Adrenal Gland Neoplasms; Antihypertensive Agents; Chromogranin A; Diabetes Mellitus, | 2011 |